24Q-62083-36141
4 vaccinations
2 coded responses
45 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-14
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
-
2021-05-05
Dose 2 — Pfizer-BioNTech
- 2021-05-05
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-05-12
- 2021-05-19
-
2021-05-29
Survey response — day 21, dose 2MedDRA: Ageusia, Anosmia, Cough, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to workMedDRA releases: 2021-09,2023-04,2024-11
- 2021-06-02
- 2021-06-10
- 2021-06-16
- 2021-08-04
-
2021-11-03
Dose 3 — Pfizer-BioNTech
- 2021-11-03
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-03
- 2021-12-10
- 2021-12-21
- 2022-02-02
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Seasonal allergy — Feeling: FairMedDRA releases: 2024-11
- 2022-11-05
-
2022-11-22
Dose 4 — Pfizer-BioNTech
-
2022-11-22
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2022-11-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Swelling, Itching · HeadacheAdult check-in
- 2022-11-24
- 2022-11-25
- 2022-11-26
- 2022-11-27
- 2022-12-01
- 2022-12-20
- 2022-12-29
- 2023-01-05
- 2023-02-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Pfizer-BioNTech | |
| 2 | 2021-05-05 | Pfizer-BioNTech | |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
| 4 | 2022-11-22 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Seasonal allergy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release